US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist
  • 1.360
  • -0.010-0.73%
Close Feb 14 16:00 ET
  • 1.370
  • +0.010+0.74%
Post 19:10 ET
76.93MMarket Cap-4.86P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Feb 4 07:36
    NEWS
    $Icecure Medical (ICCM.US)$
    IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
    Tuesday, 4th February at 8:30 am
    Two independent studies of ProSense® cryoablation in breast cancer were presented, one of which won the Highest Scoring Abstract Award in its category
    Hands-on ProSense® training featured during the S...
    Trytosaveabit
    Trytosaveabit
    Jan 27 07:37
    update
    $Icecure Medical (ICCM.US)$ Icecure Files for Regulatory Approval of Prosense® Cryoablation System in China
    Jaguar8
    Jaguar8
    Jan 27 07:31
    NEWS
    $Icecure Medical (ICCM.US)$
    IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
    Monday, 27th January at 8:30 am
    Seeks to expand regulatory approval in China where IceSense3 has already been approved
    CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, t...
    Jaguar8
    Jaguar8
    Jan 13 06:03
    NEWS
    $Icecure Medical (ICCM.US)$
    IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
    Monday, 13th January at 7:00 am
    Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors.
    FDA decision on market authorization of ProSense® for early-stage breast cancer is expected in the first quarter of 2025.
    FDA Advisory Panel voted in favor of ProSense®'...
Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+25.21%
Beijing Highlander Digital Technology
300065
+20.05%
4
Xiamen Hongxin Electronics Technology Group Inc.
300657
+20.01%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?
Earnings Season Underway
Earnings season is here. What to know?